Overview

Drug-Drug Interaction Between PK101-001 and PK101-002

Status:
Completed
Trial end date:
2019-04-24
Target enrollment:
Participant gender:
Summary
To evaluate the drug-drug interaction of PK101-001 and PK101-002 in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
PMG Pharm Co., Ltd